VTAK

8-K - Flyte Aviation, Inc. (0001716621) (Filer)

8-K - Flyte Aviation, Inc. (0001716621) (Filer)

8-K - Flyte Aviation, Inc. (0001716621) (Filer)

8-K - Flyte Aviation, Inc. (0001716621) (Filer)

8-K - Catheter Precision, Inc. (0001716621) (Filer)

FORT MILL, S.C., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) (the "Company"), today announced its Board of Directors has approved changing its name and ticker symbol to Flyte Aviation, Inc. and "VJET," respectively. Additionally, the Company will effect a one-for-ten reverse stock split -- as had been approved by stockholders at a Special Meeting of Stockholders April 15, 2026.   Every ten shares of common stock will be combined into one share, reducing the outstanding shares from approximately 21.0 million to approximately 2.1 million, with no change to the par value or authorized shares. The reverse stock split will not alter any stockholder’s percentage owner

Partnership Expands Flyte’s Growing Presence Across Entertainment, Fashion, Hospitality, Sports and Premium Destination Travel 2026 Flyte Breakthrough Awards will Honor Anthony Ippolito, Star of Amazon MGM Studios’ "I Play Rocky," Rosalind Eleazar of Chris Rock’s "Misty Green," and A24’s Jordan Firstman Flyte Brand to be Prominent Throughout this Prestigious Eleven-Day Festival Bringing Together Leading Actors, Filmmakers, Executives and Audiences from Around the World FORT MILL, S.C., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced it has established a partnership with the Hamptons International F

8-K - Catheter Precision, Inc. (0001716621) (Filer)

LockeT Has Expanded to Six Hospitals in Brazil Since Its August Launch Company Engages Experienced Cardiology Group to Support Expansion Across Argentina, Chile, Colombia and Additional Latin American Markets FORT MILL, S.C., Sept. 17, 2026 (GLOBE NEWSWIRE) --  Catheter Precision Inc. (NYSE American: VTAK), Catheter Precision, Inc. (NYSE:VTAK) ("Catheter Precision" or the "Company"), a U.S.-based medical device company specializing in cardiac electrophysiology, today announced the expansion of its LockeT commercialization efforts across Latin America following the product’s successful introduction in Brazil. LockeT launched commercially in São Paulo in August through the Company’s distr

Strategic Partnership Positions Flyte at the Intersection of Private Aviation, Fashion, and Entertainment Collaboration Introduces Flyte to a High-Value Audience of Celebrities, Executives, Creators and Cultural Tastemakers New York Fashion Week Partnership Advances Flyte’s Strategy to Build a Leading Private Aviation Brand Around Premier Destinations, Events and Experiences FORT MILL, S.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced a strategic partnership with acclaimed New York fashion designer Christian Cowan in connection with New York Fashion Week, bringing together private aviation and f

Landmark international milestone unlocks significant new markets and broadens Flyte’s addressable aviation footprint beyond the United StatesNew capabilities connect Flyte’s growing Florida network with high-demand leisure and resort destinations throughout The Bahamas and Caribbean Flyte to begin immediate commercialization through direct-to-consumer marketing and strategic partnerships, targeting increased demand, aircraft utilization and customer growth FORT MILL, S.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced that it has received the necessary approvals to expand flight operations from the United States into The

DEF 14A - Catheter Precision, Inc. (0001716621) (Filer)

Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business  Johns Hopkins Hospital, a world-renowned academic medical center, Places First Order for LockeT, VTAK’s suture retention device Places its first VIVO 3D Imaging System with a hospital in Germany, one of the largest electrophysiology markets in Europe. FORT MILL, S.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc.’s (NYSE:VTAK) medical device business unit specializing in cardiac electrophysiology solutions, today announced significant commercial growth across its LockeT and VIVO product lines, marked by new U.S. distribution cha

424B3 - Catheter Precision, Inc. (0001716621) (Filer)

PRE 14A - Catheter Precision, Inc. (0001716621) (Filer)

New Account Creation Increased 170% During the First 17 Days of August Compared to the Same Period in July Flyte Has Added More Accounts Since July 1 Than During the Entire First Half of 2026 Growing First-Party Customer Base Now Spans 174 Airports Across 19 States FORT MILL, S.C., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced that more than 10,000 consumer accounts are now registered on the Flyte WebApp, marking a significant milestone as new account creation continues to accelerate across the Company’s technology-enabled private aviation platform. During the first 17 days of August, Flyte added

Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations FullPAC (NASDAQ Reserved Ticker: GOTV) to Introduce Flyte’s Cirrus Vision Jet Network to Qualified Congressional, Senate, Gubernatorial and Attorney General Campaigns Across the Eastern United States FORT MILL, S.C., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK), doing business as Flyte, a technology-enabled regional aviation company redefining short-haul private air travel, today announced a strategic partnership with FullPAC (NASDAQ reserved ticker: GOTV), an AI-powere

10-Q - Catheter Precision, Inc. (0001716621) (Filer)

Strategic Partnership Places Flyte at the Center of One of the Nation's Premier Communities of Founders, Investors, and Operators Collaboration Reflects Flyte's Continued Commitment to Building Relationships Within the Entrepreneurial and Venture Capital Ecosystem FORT MILL, S.C., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced a strategic partnership with The Nucleus Network, a rapidly growing community connecting founders, investors, executives, and innovators, to support the inaugural "The Nucleus" event taking place August 15th at 4:00 p.m. As an official partner, Flyte will participate i

July 2026 Revenue Increased 102% sequential July Over June to Approximately $640,000 Retail Platform, Strategic Partnerships and Influencer Marketing Fuel Accelerating Growth FORT MILL, S.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK"), today announced record monthly revenue for July 2026, marking the strongest operating month in Flyte’s history as demand continues to accelerate across its private aviation platform. Since launching its enhanced direct-to-consumer platform, Flyte has acquired more than 2,700 new users, reflecting continued demand for the Company's technology-enabled booking platform and growing awareness of the F

Enterprise Artificial Intelligence Deployment Expected to Enhance Customer Experience, Improve Operating Efficiency, and Increase Workforce Productivity Across Flight Operations Technology Strengthens Flyte’s Scalable Regional Air Mobility Platform Through Intelligent Automation, Operational Excellence, and Long-Term Growth Initiatives FORT MILL, S.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) ("Catheter Precision" or the "Company"), through its wholly owned subsidiary Flyte, today announced that Flyte has become the inaugural enterprise customer of Volato AI (NYSE:SOAR), a purpose-built enterprise artificial intelligence platform designed specifically for bu

Purpose-built platform introduces aviation-specific AI agents to improve productivity, customer responsiveness, and operating efficiency Commercial launch complements Volato’s primary strategic focus on completing an AI infrastructure business combination Volato Group, Inc. (NYSE:SOAR) ("Volato" or the "Company") today announced the commercial launch and first enterprise deployment of Volato AI, its purpose-built enterprise artificial intelligence platform for business aviation. Flyte, a technology-enabled regional air mobility company owned by Catheter Precision, Inc. (NYSE:VTAK), will serve as the platform’s inaugural enterprise customer. Volato remains principally focused on advanc

8-K - Catheter Precision, Inc. (0001716621) (Filer)

Exclusive Partnership Offers The Maidstone Guests Access and Savings on Flyte's Private Travel Services Collaboration Marks the Beginning of a Long-Term Relationship Connecting Luxury Hospitality with Modern Private Aviation FORT MILL, S.C., July 29, 2026 (GLOBE NEWSWIRE) --  Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced a strategic partnership with The Maidstone, one of the Hamptons' most iconic luxury boutique hotels, bringing Flyte's private aviation experience directly to The Maidstone's guests. Through the partnership, guests of The Maidstone will receive exclusive preferred pricing with Flyte when traveling to the Hamptons,

8-K/A - Catheter Precision, Inc. (0001716621) (Filer)